As the cost of prescription drugs generates increased controversy, Express Scripts (ESRX), the nation’s largest pharmacy benefit manager, will be removing still more medicines from its list of drugs covered by insurance, known as formularies.

In 2019, the PBM will exclude 242 medicines, compared with 196 this year, and the changes are forecast to save about $3.2 billion for its clients, such as health plans. The formulary covers approximately 25 million people, and about 0.2 percent of them are forecast to be affected by the changes.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • I am currently enrolled in tri care express scripts. Will I be notified if any of my drugs will be eliminated.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy